Walmart says ready to administer millions of COVID-19 vaccine boosters
Reuters
Published Aug 31, 2021 05:34PM ET
Updated Aug 31, 2021 11:16PM ET
(Reuters) - Walmart (NYSE:WMT) Inc on Tuesday became the latest U.S. retailer to say that it is ready to administer millions of COVID-19 booster vaccine doses this fall if U.S. health officials endorse such a shot to improve fading immunity against the coronavirus.
Rivals CVS Health Corp (NYSE:CVS) and Kroger (NYSE:KR) Co earlier this month had announced plans to make booster shots available at their stores, pending regulatory guidance.
U.S. health regulators have authorized a third dose of the vaccines made by Pfizer (NYSE:PFE) and partner BioNTech as well as Moderna (NASDAQ:MRNA) for those with weak immune systems, and the government has said it plans to make booster doses available to more Americans in September.
The need for boosters, however, has not yet been recommended by health regulators.
The U.S. Centers for Disease Control and Prevention (CDC) on Monday said it may be difficult to determine at this point whether immunity from prior vaccination is waning over time or if the vaccines are just less able to prevent infection by the highly-transmissible Delta variant.
Walmart, which runs one of the largest U.S. pharmacy chains, and its Sam's Club pharmacies are currently administering the third dose to immunocompromised individuals.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.